Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS)

Headlines for Anadys Pharmaceuticals, Inc.

Unusual Options Activity Review - AES, HOLX, GME, ANDS, SFSF, TRA, JOSB, CAKE, .VIX, FXI
The Options Insider - Mar 12, 2010
AES is the subject of unusual options activity this week. Open interest, or the number of contracts that have been opened by investors, in January 12.5 strike calls increased by more than 40,000 ...
Options Intelligence Report: Anadys Pharm-Bull Eyes Upside, Buys Call Spread
istockAnalyst.com - Mar 11, 2010
Anadys Pharmaceuticals, Inc. (ANDS) – Biotechnology firm, Anadys Pharmaceuticals, enticed a long-term bullish investor to shell out option premium in order to establish a debit call spread in the ...
Options Intelligence Report: Anadys Pharmaceuticals, Inc. (ANDS), iShares FTSE/Xinhua China 25 Index Fund (FXI) & GameStop Corp. (GME) - The Options Insider
Anadys draws September call spread
optionMONSTER Research - Mar 11, 2010
Anadys Pharmaceuticals plunged last month on disappointing drug-trial data, and now one investor is betting on a huge rebound. optionMONSTER's Heat Seeker tracking system detected the purchase of ...
Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
PR Newswire - Mar 9, 2010
SAN DIEGO, March 9 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the ROTH 22nd Annual OC Growth Stock Conference on Tuesday, March ...
Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
PR Newswire - Mar 1, 2010
SAN DIEGO, March 1 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 30th Annual Cowen and Company Healthcare Conference on Monday ...